scholarly article | Q13442814 |
P356 | DOI | 10.1074/MCP.M300094-MCP200 |
P698 | PubMed publication ID | 14593079 |
P2093 | author name string | Yan Li | |
Rong Zeng | |||
Hong-Yang Wang | |||
Qi-Chang Xia | |||
Zhao-You Tang | |||
Jia-Rui Wu | |||
Sheng-Long Ye | |||
Shi-Jian Ding | |||
Bo Tian | |||
Ye-Xiong Tan | |||
Xiao-Xia Shao | |||
Man-Rong Jiang | |||
Ying-Kun Liu | |||
P2860 | cites work | Onset of re-epithelialization after skin injury correlates with a reorganization of keratin filaments in wound edge keratinocytes: defining a potential role for keratin 16 | Q24672122 |
Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels | Q27860531 | ||
The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells | Q28262541 | ||
A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry | Q30660638 | ||
Proteome alterations in human hepatoma cells transfected with antisense epidermal growth factor receptor sequence | Q30724074 | ||
Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials | Q33200413 | ||
The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
Expression of complete keratin filaments in mouse L cells augments cell migration and invasion | Q36288957 | ||
Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer | Q37340550 | ||
New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis | Q38273658 | ||
Elevation of cytokeratin 19 fragment in serum in patients with hepatoma: its clinical significance | Q40821157 | ||
Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry | Q40853089 | ||
Keratin 19 downregulation by oral squamous cell carcinoma lines increases invasive potential | Q40947817 | ||
Role of intermediate filaments in migration, invasion and metastasis | Q41349193 | ||
Cytokeratin expression during AFB1-induced carcinogenesis | Q41730030 | ||
P433 | issue | 1 | |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
overexpression | Q61643320 | ||
P304 | page(s) | 73-81 | |
P577 | publication date | 2003-10-30 | |
P1433 | published in | Molecular & Cellular Proteomics | Q6895932 |
P1476 | title | From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis | |
P478 | volume | 3 |
Q43634441 | Alteration in apoptosis and cell cycle by celecoxib and/or fish oil in 7,12-dimethyl benzene (α) anthracene-induced mammary carcinogenesis |
Q36732510 | Analysis of phenotype-genotype connection: the story of dissecting disease pathogenesis in genomic era in China, and beyond |
Q36111028 | Application of proteomics in the study of tumor metastasis |
Q57422139 | CK19 and CD99 Immunoexpression Profile in Goblet Cell (Mucin-Producing Neuroendocrine Tumors) and Classical Carcinoids of the Vermiform Appendix |
Q35258032 | CK19 is a sensitive marker for yolk sac tumours of the testis |
Q40022052 | Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma |
Q42207466 | Changes in glucose-6-phosphate dehydrogenase expression results in altered behavior of HBV-associated liver cancer cells |
Q48118614 | Chronic inflammation-elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance |
Q53386792 | Comprehensive profiling of metastasis-related proteins in paired hepatocellular carcinoma cells with different metastasis potentials. |
Q53898691 | Contribution of proteomics to the study of the role of cytokeratins in disease and physiopathology. |
Q33751830 | Coronin-1C is a novel biomarker for hepatocellular carcinoma invasive progression identified by proteomics analysis and clinical validation |
Q54444216 | CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma. |
Q87677698 | Cytokeratin 7/19 expression in N-diethylnitrosamine-induced mouse hepatocellular lesions: implications for histogenesis |
Q38673577 | Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis |
Q33275840 | Detection of the inferred interaction network in hepatocellular carcinoma from EHCO (Encyclopedia of Hepatocellular Carcinoma genes Online). |
Q42318305 | Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis. |
Q33531276 | Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis. |
Q39653490 | Epidermal growth factor induces cytokeratin 19 expression accompanied by increased growth abilities in human hepatocellular carcinoma |
Q37462365 | Experimental models of hepatocellular carcinoma: developments and evolution |
Q36110393 | Expression of K19 and K7 in dysplastic nodules and hepatocellular carcinoma |
Q57149606 | Expression of bile duct transcription factor HNF1β predicts early tumor recurrence and is a stage-independent prognostic factor in hepatocellular carcinoma |
Q35745018 | Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma |
Q82589019 | Expression of cytokeratin 19 and matrix metalloproteinase 2 predicts lymph node metastasis in hepatocellular carcinoma |
Q92891477 | Expression pattern of placenta specific 8 and keratin 20 in different types of gastrointestinal cancer |
Q81120947 | Ezrin expression is associated with hepatocellular carcinoma possibly derived from progenitor cells and early recurrence after surgical resection |
Q39562944 | FLNA and PGK1 are two potential markers for progression in hepatocellular carcinoma |
Q37277185 | Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer |
Q33556895 | Functional proteomic analysis reveals the involvement of KIAA1199 in breast cancer growth, motility and invasiveness |
Q36638176 | Hepatic progenitor cells in human liver tumor development |
Q34744836 | Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection |
Q35531664 | Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts |
Q51775017 | Hepatocellular carcinoma in individuals with HBV infection or HBV-HCV co-infection in a low endemic country. |
Q34633249 | Hepatocellular carcinoma: insight from animal models |
Q53467129 | Histopathological classification of hepatocellular carcinoma. |
Q34651211 | Human acyl-CoA:cholesterol acyltransferase 2 gene expression in intestinal Caco-2 cells and in hepatocellular carcinoma. |
Q50937876 | ITMSQ: A software tool for N- and C-terminal fragment ion pairs based isobaric tandem mass spectrometry quantification. |
Q36946778 | Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers |
Q37084179 | Influence of reproductive tract obstruction on expression of epididymal proteins and their restoration after patency |
Q54719345 | Inhibitory effect of phytoglycoprotein (24 kDa) on hepatocarcinogenesis in N-nitrosodiethylamine-treated ICR mice. |
Q64928988 | Intermediate Filaments as Effectors of Cancer Development and Metastasis: A Focus on Keratins, Vimentin, and Nestin. |
Q33711578 | Keratin 19 marks poor differentiation and a more aggressive behaviour in canine and human hepatocellular tumours |
Q38725581 | Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver. |
Q33997118 | Liver stem cells and their implication in hepatocellular and cholangiocarcinoma |
Q53398114 | MRI features of hepatocellular carcinoma expressing progenitor cell markers. |
Q35619951 | MRI features of hepatocellular carcinoma related to biologic behavior |
Q34164408 | MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma |
Q39038889 | Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma |
Q40125882 | Prognostic significance of serum procalcitonin in patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization: A retrospective analysis of 509 cases |
Q38584282 | Proteome Analyses of Hepatocellular Carcinoma |
Q33290708 | Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues |
Q39642084 | Proteome analysis of human pancreatic cancer cell lines with highly liver metastatic potential by antibody microarray |
Q38475218 | Proteomic analysis of the nuclear matrix in the early stages of rat liver carcinogenesis: identification of differentially expressed and MAR-binding proteins. |
Q30157380 | Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells |
Q39515451 | Proteomic profiling between CNE-2 and its strongly metastatic subclone S-18 and functional characterization of HSP27 in metastasis of nasopharyngeal carcinoma |
Q33268322 | Proteomic profiling identifies breast tumor metastasis-associated factors in an isogenic model |
Q37769478 | Proteomics in China: ready for prime time |
Q39915284 | Quantitative proteome analysis of HCC cell lines with different metastatic potentials by SILAC. |
Q42784778 | Quantitative proteomic analysis of a paired human liver healthy versus carcinoma cell lines with the same genetic background to identify potential hepatocellular carcinoma markers |
Q39049068 | RNA interference targeting human integrin α6 suppresses the metastasis potential of hepatocellular carcinoma cells |
Q37474142 | Radiofrequency ablation following first-line transarterial chemoembolization for patients with unresectable hepatocellular carcinoma beyond the Milan criteria |
Q35056704 | Rho kinase phosphorylation promotes ezrin-mediated metastasis in hepatocellular carcinoma |
Q36015365 | Risk Factors for Distant Metastasis in Patients with Minimally Invasive Follicular Thyroid Carcinoma |
Q63641946 | Role of p53 and β-catenin Mutations in Conjunction with CK19 Expression on Early Tumor Recurrence and Prognosis of Hepatocellular Carcinoma |
Q38704948 | Screening and identification of the tumor-associated antigen CK10, a novel potential liver cancer marker |
Q41715032 | Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma |
Q40264763 | Serum CYFRA 21-1 level reflects hepatocellular carcinoma metastasis: study in nude mice model and clinical patients |
Q34501851 | Serum tumor markers for detection of hepatocellular carcinoma |
Q40555471 | Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics |
Q24797522 | System-based proteomic analysis of the interferon response in human liver cells |
Q35710117 | TCF12 protein functions as transcriptional repressor of E-cadherin, and its overexpression is correlated with metastasis of colorectal cancer |
Q28071619 | The Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular Carcinoma |
Q64060035 | The Role of MicroRNAs in Hepatoblastoma Tumors |
Q35923530 | The keratin cytoskeleton in liver diseases |
Q40694579 | The meaning of gross tumor type in the aspects of cytokeratin 19 expression and resection margin in patients with hepatocellular carcinoma |
Q35582077 | Time-dependent effect of hypoxia on tumor progression and liver progenitor cell markers in primary liver tumors |
Q81083940 | Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor |
Q46693261 | Two-dimensional differential gel electrophoresis/analysis of diethylnitrosamine induced rat hepatocellular carcinoma |
Q35847118 | Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration |
Search more.